Development Level

Tclin 5 | 602
Tchem 2 | 1,890

Disease

Cancer 6 | 2,346
psoriasis 6 | 6,685
Asthma 5 | 349
Inflammatory bowel disease 5 | 142
Alzheimer's disease 4 | 644
Arthritis 4 | 248
Endometriosis 4 | 535
Hepatitis B 4 | 103
Hyperglycemia 4 | 120
Kidney disease 4 | 396
Liver disease 4 | 219
Mammary Neoplasms 4 | 410
Neuropathy 4 | 210
Pancreatitis 4 | 97
Rheumatoid Arthritis 4 | 1,160
Uveitis 4 | 103
cystic fibrosis 4 | 1,665
diabetes mellitus 4 | 1,663
ulcerative colitis 4 | 2,087
Acute kidney injury 3 | 65
Allergic hypersensitivity disease 3 | 123
Allergic rhinitis 3 | 91
Anemia 3 | 252
Arthritis, Experimental 3 | 39
Atherosclerosis 3 | 275
Autistic Disorder 3 | 320
Brain Ischemia 3 | 87
Bronchitis 3 | 44
Candidiasis 3 | 48
Colitis 3 | 46
Collagen disease 3 | 25
Common cold 3 | 63
Crohn Disease 3 | 97
Dermatitis 3 | 107
Diabetic Retinopathy 3 | 53
Diarrhea 3 | 155
Disseminated intravascular coagulation 3 | 32
Eosinophilia 3 | 65
Gastritis 3 | 44
Glomerulonephritis 3 | 36
Heart disease 3 | 279
Heat Stroke 3 | 12
Hepatitis C 3 | 90
Hepatolenticular Degeneration 3 | 24
Hyperalgesia 3 | 71
Hypersensitivity reaction type II disease 3 | 235
Infertility 3 | 163
Inflammation 3 | 109
Inflammatory Bowel Diseases 3 | 87
Influenza 3 | 142
Kawasaki disease 3 | 24
Keratitis 3 | 42
Leishmaniasis 3 | 49
Leishmaniasis, Visceral 3 | 13
Leukopenia 3 | 42
Listeriosis 3 | 17
Liver carcinoma 3 | 217
Lung Neoplasms 3 | 171
Lung disease 3 | 132
Malaria 3 | 140
Mastitis 3 | 48
Meningitis 3 | 46
Multiple Sclerosis 3 | 498
Myocardial Infarction 3 | 126
Myocardial Ischemia 3 | 169
Obesity 3 | 616
Peritonitis 3 | 37
Pleurisy 3 | 18
Pneumonia 3 | 133
Polycystic Ovary Syndrome 3 | 332
Primary immunodeficiency disease 3 | 52
Prostatic Neoplasms 3 | 471
Prostatitis 3 | 15
Reperfusion Injury 3 | 84
Tetanus 3 | 66
Thrombocytopenia 3 | 105
Toxic shock syndrome 3 | 28
Vascular disease 3 | 281
acute myeloid leukemia 3 | 780
astrocytoma 3 | 1,493
interstitial cystitis 3 | 2,299
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,988
malignant mesothelioma 3 | 3,162
osteosarcoma 3 | 7,933
ovarian cancer 3 | 8,484
periodontitis 3 | 269
posterior fossa group A ependymoma 3 | 1,511
sarcoidosis 3 | 358
tuberculosis 3 | 1,557
Acquired immunodeficiency syndrome 2 | 164
Ankylosing spondylitis 2 | 138
Brain disease 2 | 83
Dermatologic disorders 2 | 65
Diabetes Mellitus, Experimental 2 | 106
Diabetes Mellitus, Insulin-Dependent 2 | 76
Drug-Induced Liver Injury 2 | 118
Heart failure 2 | 80
Liver Cirrhosis, Experimental 2 | 108
Parkinson Disease 2 | 102
interstitial lung disease 2 | 291

Tissue

Blood and immune system 7 | 17,995
Cardiovascular System 7 | 17,958
Digestive Tract 7 | 18,473
Endocrine System 7 | 18,512
Female tissues 7 | 18,647
Liver and Pancreas 7 | 18,136
Male tissues 7 | 17,969
Nervous System 7 | 18,561
Respiratory system 7 | 17,484
Skin and soft tissues 7 | 18,115
Urinary Tract 7 | 18,444

Target Family

Non-IDG 4 | 11,971
Enzyme 2 | 4,146
Nuclear Receptor 1 | 48

Grant Application

5R01GM071036-02 7 | 7
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
NF-kappa-B inhibitor alpha NFKBIA Tchem Non-IDG -3.34160 1960.9 1181
Aldose reductase AKR1B1 Tclin Enzyme -3.24467 1851.0 302
Tumor necrosis factor TNF Tclin Non-IDG -4.68994 50044.6 2261
Neutrophil elastase ELANE Tclin Enzyme -3.59079 3832.0 322
Androgen receptor AR Tclin Nuclear Receptor -3.78107 6683.7 1366
Interleukin-10 IL10 Tchem Non-IDG -4.03858 11514.6 1151
Interleukin-6 IL6 Tclin Non-IDG -4.44733 28484.7 1664